Articles dans des revues avec comité de lecture (364)

  1. 190. De Bruyn, C., Delforge, A., & Bron, D. (2004). Ex vivo expansion of mobilized peripheral blood myeloid prognenitor cells: pretreated patients vs normal donors. Blood, 104, 120.
  2. 191. Gorin, N. C., Feremans, W., Bron, D., et al. (2003). Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: Influence of dose and stem cell source shows better outcome with rich marrow. Blood, 102(8), 3043-3051. doi:10.1182/blood-2003-03-0665
  3. 192. Bosly, A., Sonet, A., Pinkerton, C. R., McCowage, G., Bron, D., Sanz, M. A., & Van den Berg, H. (2003). Rasburicase (recombinant urate oxidase) for the management of hyperuricemia in patients with cancer: report of an international compassionate use study. Cancer, 98(5), 1048-1054. doi:10.1002/cncr.11612
  4. 193. Aleman, B., Raemaekers, J. M. M., Tirelli, U., Bortolu, R., Van't Veer, M., Lybeert, M., Keuning, J., Carde, P., Girinsky, T., Van der Maazen, R., Tomsic, R., Vovk, M., van Hoof, A., Demeestere, G., Lugtenburg, P., Thomas, J., Schroyens, W., de Boeck, K., Baars, J. W., Kluin-Nelemans, H. C., Carrie, C., Aoudjhane, M., Bron, D., Eghbali, H., Smit, W., Meerwaldt, J. H., Hagenbeek, A., Pinna, A., & Henry-Amar, M. (2003). Involved-field radiotherapy for advanced Hodgkin's lymphoma. The New England journal of medicine, 348(24), 2396-2406.
  5. 194. Lagneaux, L., de Meulenaer, E. C., Delforge, A., Dejeneffe, M., Massy, M., Moerman, C., Hannecart, B., Canivet, Y., Lepeltier, M. F., & Bron, D. (2003). Ultrasonic low-energy treatment: a novel approach to induce apoptosis in human leukemic cells. Experimental hematology, 30(11), 1293-1301. doi:10.1016/S0301-472X(02)00920-7
  6. 195. De Bruyn, C., Delforge, A., & Bron, D. (2003). Ex vivo myeloid differentiation of cord blood CD34+ cells: comparison of four serum-free media containing bovine or human albumin. Cytotherapy, 5(2), 153-160. doi:10.1080/1465324031001055
  7. 196. André, M. J., Baudoux, E., Bron, D., Canon, J.-L., D'Hondt, V., Fassotte, M.-F., D'Hondt, L., Fillet, G., Humblet, Y., Jerusalem, G., Vermeulen, P., Symann, M., & Beguin, Y. (2003). Phase III randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion, 43(1), 50-57. doi:10.1046/j.1537-2995.2003.00273.x
  8. 197. Lewalle, P., Triffet, A., Delforge, A., Crombez, P., Selleslag, D., De Muynck, H., Bron, D., & Martiat, P. (2003). Donor lymphocyte infusions in adult haploidentical transplant: a dose finding study. Bone marrow transplantation, 31(1), 39-44. doi:10.1038/sj.bmt.1703779
  9. 198. De Bruyn, C., Delforge, A., Bernier, M., & Bron, D. (2003). Ex vivo expansion of neutrophil precursor cells from fresh and cryopreserved cord blood cells. Cytotherapy, 5(1), 87-98. doi:10.1080/14653240310000119
  10. 199. De Bruyn, C., Delforge, A., & Bron, D. (2003). Ex vivo expansion of cord blood and mobilized peripheral blood CD34+ cells into megakaryocytes: detrimental effect of Flt3-ligand, stem cell factor and interleukin 3. Blood, 102, 421.
  11. 200. De Bruyn, C., Delforge, A., & Bron, D. (2003). Cord blood CD34+ cells do not differentiate successfully in megakaryocytes in vitro as compared with mobilized peripheral blood cells: negative effects of the addtion of stem cell factor to thrombopoietin. Experimental hematology, 31, 155.
  12. 201. Ruscas-Craciun, L. I., Stordeur, P., Schandené, L., Duvillier, H., Bron, D., Lambermont, M., Goldman, M., & Dupont, E. (2002). Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation, 74(7), 995-1000. doi:10.1097/01.TP.0000031933.82269.AC

  13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37
    38 Suivant >>